drugset / Trial / NCT00999115

Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn's Disease (ALOREVA)

NCT00999115 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine safety and efficacy of allogenic eASCs (expanded adult stem cells) for the treatment of recto-vaginal fistula in patients with Crohn´s disease.

Timeline

Start
2009-09
Primary completion
2010-12
Completion
2011-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Expanded allogenic adipose-derived adult stem cells Cell therapy 20 cells Intramuscular
Subject Expanded allogenic adipose-derived adult stem cells Cell therapy 40 cells Intramuscular